GlassScriptPhysician profile
Samuel S Newman
NPI 1841265519
$1,523.21
in general payments reported to CMS, 2019-2025
21 companies · $44.44 in 2025
The $44.44 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2021: $289 · 2022: $162 · 2023: $187 · 2024: $94.62 · 2025: $44.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $437.38 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $282.93 | 2019-2021 | |
| Endologix LLC | $182.55 | 2019 | |
| Abbott Laboratories | $94.13 | 2023 | Jeti |
| Allergan, INC. | $71.00 | 2019-2021 | |
| Smith+Nephew, INC. | $59.05 | 2022-2024 | Collagenase Santyl |
| Abbvie INC. | $53.33 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $52.09 | 2022 | |
| Medtronic, INC. | $41.47 | 2024-2025 | Hawkone, Progrip |
| Takeda Pharmaceuticals U.S.A., INC. | $38.09 | 2022-2023 | Gattex |
| Chiesi USA, INC. | $32.99 | 2021 | |
| Merck Sharp & Dohme LLC | $24.15 | 2019 | |
| Getinge USA Sales, LLC | $23.75 | 2019 | |
| Organogenesis INC. | $22.74 | 2023 | Puraply |
| Boston Scientific Corporation | $20.62 | 2025 | Enroute Transcarotid Neuroprotection System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $17.17 | 2024 | Zynrelef |
| Convatec INC. | $16.29 | 2019 | |
| Covidien LP | $15.27 | 2019 | |
| Avinger INC. | $14.62 | 2023 | Pantheris |
| Lemaitre Vascular, INC. | $12.32 | 2023 | Restoreflow |
| Paratek Pharmaceuticals, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.